Balanced news tone
News Sentiment
IRMD sentiment intelligence
Iradimed Co news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
59 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-3.7% over one week, +3.8% over four weeks, trend inactive, and materially above fair value.
Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-3.7%
Price reacting lower
Trend fit
Trend inactive
3.8% over four weeks
Fair value
61.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
41
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Moomoo
Direct company coverage
Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 12:26
- Source
- Moomoo
Stock Traders Daily
Direct company coverage
Precision Trading with Iradimed Corporation (IRMD) Risk Zones
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 08 Jul 2026 06:38
- Source
- Stock Traders Daily
TradingView
Direct company coverage
Price to book forward of iRadimed Corporation – NASDAQ:IRMD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 09:35
- Source
- TradingView
dars.gov.et
Direct company coverage
iRadimed (IRMD) Q1 2026 Earnings: EPS Beats Estimates by 7.95%; Stock Rises - Guidance Update
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 Jul 2026 08:31
- Source
- dars.gov.et
TradingView
Direct company coverage
Price to book forward of IRadimed Corp. – LS:A118V4
This article provides financial information for IRadimed Corp. (LS:A118V4), specifically focusing on its price-to-book forward ratio. It includes an overview of the company's financials on TradingView, such as market data provided by ICE Data Services and reference data from Fact
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 09:10
- Source
- TradingView
Finviz
Direct company coverage
IRMD - Iradimed Corp Latest SEC Filings
This article provides the latest SEC filings and a comprehensive overview of Iradimed Corp (IRMD) financials and performance metrics. It details key financial figures such as market cap, income, sales, and various ratios, alongside stock performance, insider and institutional own
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 13:40
- Source
- Finviz
TradingView
Direct company coverage
Price to book forward of IRadimed Corp. – HAN:46K
This article provides the "Price to book forward" metric for IRadimed Corp. (HAN:46K) trading on the Hannover Stock Exchange. It is a financial data point without further analysis or contextual information.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 04:41
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K
This article presents the enterprise value to revenue forward for IRadimed Corp. (HAN:46K) as listed on the Hannover Stock Exchange. Although the article provides no specific numerical data, it frames the company's financial metric within the context of a stock exchange listing.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 13:39
- Source
- TradingView
TradingView
Direct company coverage
IRadimed Corp. Actuals & Estimates (DUS:46K)
This article provides an overview of IRadimed Corp. (DUS:46K) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It covers analyst forecasts for the stock, historical price performance, upcoming earnings dates, and details on past earn
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 10:10
- Source
- TradingView
TradingView
Direct company coverage
46K Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for IRadimed Corp. (46K) stock, based on analyst opinions. It includes details on maximum and minimum price estimates, past financial performance, upcoming earnings dates, dividend information, and company metrics like EBITDA and
- Tone
- Positive 63/100
- Event
- Analyst action
- Published
- 26 Jun 2026 11:39
- Source
- TradingView
TradingView
Direct company coverage
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD)
This article provides an overview of iRadimed Corporation (NASDAQ: IRMD) including financial actuals, estimates, and analyst forecasts. It covers key metrics like current stock price, historical highs and lows, market capitalization, earnings, revenue, dividends, and volatility,
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 26 Jun 2026 09:10
- Source
- TradingView
Stock Titan
Direct company coverage
Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay
Iradimed Corporation's shareholders held their annual meeting, where they elected Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins to the board of directors. They also approved RSM US LLP as the independent auditor for the fiscal year ending December 31
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 14:39
- Source
- Stock Titan
Investing.com Australia
Direct company coverage
Form 4 Iradimed Co For: 23 June By Investing.com
This article from Investing.com is a regulatory filing update titled "Form 4 Iradimed Co For: 23 June." It reports on the Form 4 filing for Iradimed Co (IRMD) made on June 23rd, 2026, indicating insider transactions for the company. The article contains the title, publication dat
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 23 Jun 2026 23:09
- Source
- Investing.com Australia
Stock Titan
Direct company coverage
IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes
IRADIMED CFO John Glenn converted 5,796 restricted stock units (RSUs) into common shares on June 20, 2026. He then disposed of 2,319 shares to cover tax obligations, which was a tax-withholding transaction, not an open-market sale. Following these transactions, Glenn directly hol
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 13:10
- Source
- Stock Titan
Sahm
Direct company coverage
IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative
IRADIMED (IRMD) is currently valued by one narrative as 21.9% undervalued at $92.20 per share, with a fair value target of $118, primarily due to the anticipated replacement cycle driven by its new 3870 MRI compatible IV pump. While this narrative projects significant revenue gro
- Tone
- Positive 70/100
- Event
- Analyst action
- Published
- 22 Jun 2026 00:10
- Source
- Sahm
Intellectia AI
Direct company coverage
IRMD Technical Analysis & Stock Price Forecast
The article provides a technical analysis and stock price forecast for IRadimed Corp (IRMD), indicating a "Strong Buy" consensus based on various technical indicators and moving averages. While some indicators like RSI are neutral or sell, the MACD and several moving averages sug
- Tone
- Positive 77/100
- Event
- Guidance
- Published
- 18 Jun 2026 21:13
- Source
- Intellectia AI
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for IRadimed Corp (IRMD), indicating an earnings forecast score of 8.00 and ranking 66th in its industry. Analysts, based on 2 ratings, have an average price target of $99.00 with a "Buy" recommendation. The company's previous quarter EP
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 18 Jun 2026 20:11
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for IRadimed Corp (IRMD), highlighting its current risk assessment score of 7.77 and ranking within the Healthcare Equipment & Supplies industry. It details various risk metrics including beta, maximum drawdown, volatility, and Sharpe Ratio
- Tone
- Negative 41/100
- Event
- Market update
- Published
- 17 Jun 2026 21:40
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a detailed historical overview of IRadimed Corp's (IRMD) dividend payouts, including future declared dividends. It lists the dividend amount, record date, payment date, and ex-dividend date for various interim and final cash dividends. The report also notes
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 Jun 2026 20:11
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of IRadimed Corp (IRMD), listing major individual and institutional holders. It provides a breakdown of shareholder types and traces institutional shareholding trends over several quarters. The data includes the proportion of shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 02:11
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), categorizing its revenue by business segments and geographical regions. As of April 6, 2024, the company's largest revenue contributors are MRI Compatible IV Infusion Pump Systems and MRI Compatible Pati
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 02:11
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Institutional Confidence
IRadimed Corp (IRMD) has an institutional shareholding score of 5.00, placing it 109th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 65.08%, a 13.11% increase quarter-over-quarter. James Simons is the largest institutional sharehold
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 16 Jun 2026 20:09
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of IRadimed Corp (IRMD), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 16, 2026, IRMD's price momentum score is 7.36, and the stock is trading between resistance at $98.06 an
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 16 Jun 2026 19:40
- Source
- TradingKey
TradingKey
Direct company coverage
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis
This article provides a financial analysis of IRadimed Corp (IRMD), highlighting its strong financial health with a score of 9.60. The company ranks highly in its industry due to robust financial status, high operating efficiency, and significant year-over-year increases in reven
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 16 Jun 2026 07:40
- Source
- TradingKey
StockStory
Industry context
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
simplywall.st
Direct company coverage
Independent Director Hilda Scharen-Guivel Sold A Bunch Of Shares In IRADIMED
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jun 2026 07:00
- Source
- simplywall.st
TradingView
Direct company coverage
Number of shareholders of IRadimed Corp. – DUS:46K
The article displays an overview of IRadimed Corp. (DUS:46K) on the TradingView platform, focusing on the number of shareholders. It includes sections for financial data, news, community insights, forecasts, and stock information, indicating a market closed status with no recent
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 23:09
- Source
- TradingView
Finviz
Direct company coverage
IRMD - Iradimed Corp Stock Price and Quote
This page provides a comprehensive overview of Iradimed Corp (IRMD) stock, including its latest closing price, dollar and percentage changes, and various financial metrics such as market cap, income, sales, and P/E ratio. It also details dividend information, employee count, IPO
- Tone
- Positive 77/100
- Event
- Capital return
- Published
- 05 Jun 2026 15:10
- Source
- Finviz
Investing.com South Africa
Direct company coverage
Iradimed director sells $285,000 in company stock By Investing.com
A director at IRADIMED CORP, Hilda Frederique Scharen-Guivel, sold 3,000 shares of company stock for $285,000 on June 4, 2026. This transaction occurred amidst a strong 52% return for IRMD stock over the past year, though InvestingPro's Fair Value analysis suggests the shares may
- Tone
- Negative 33/100
- Event
- Market update
- Published
- 05 Jun 2026 04:40
- Source
- Investing.com South Africa